Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.

Hernes, E H; Linja, M; Fosså, S D; Visakorpi, T; Berner, A; Winderen, M; Koivisto, P A

Hernes, E H; Linja, M; Fosså, S D; Visakorpi, T; Berner, A; Winderen, M; Koivisto, P A.

Affiliation

Hernes EH; Departments of Oncology, Pathology and Nuclear Medicine, The Norwegian Radium Hospital, Montebello, Oslo, Norway.

BJU Int ; 86(3): 240-7, 2000 Aug.

Article in En | MEDLINE | ID: mdl-10930923

Subject(s)

Prostatic Neoplasms/mortality; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal/therapeutic use; Biopsy/methods; Bone Neoplasms/secondary; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Ki-67 Antigen/analysis; Male; Middle Aged; Neoplasm Proteins/analysis; Palliative Care/methods; Prognosis; Prostate/pathology; Prostatic Neoplasms/pathology; Prostatic Neoplasms/therapy; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: BJU Int Year: 2000 Document type: Article

Search on Google

XML

PubMed Links